stockportfolio.pro
Cytokinetics, Incorporated EPS (Earnings per Share) 1999–2025
Cytokinetics, Incorporated (CYTK) annual earnings per share by fiscal year, computed from SEC filings.
| Fiscal year | EPS (Earnings per Share) | Change (YoY) |
|---|---|---|
| FY 2025 | $-6.54 | -24.3% |
| FY 2024 | $-5.26 | +3.5% |
| FY 2023 | $-5.45 | -25.9% |
| FY 2022 | $-4.33 | -54.6% |
| FY 2021 | $-2.80 | -42.1% |
| FY 2020 | $-1.97 | — |
| FY 2019 | $0.00 | — |
| FY 2018 | $0.00 | +100.0% |
| FY 2017 | $-2.59 | -764.1% |
| FY 2016 | $0.39 | +140.2% |
| FY 2015 | $-0.97 | -136.6% |
| FY 2014 | $-0.41 | — |
| FY 2013 | $0.00 | — |
| FY 2012 | $0.00 | +100.0% |
| FY 2011 | $-4.32 | +6.5% |
| FY 2010 | $-4.62 | -130.6% |
| FY 2009 | $15.12 | — |
| FY 2008 | $0.00 | — |
| FY 2007 | $0.00 | — |
| FY 2006 | $0.00 | — |
| FY 2005 | $0.00 | — |
| FY 2004 | $0.00 | — |
| FY 2003 | $0.00 | — |
| FY 2002 | $0.00 | — |
| FY 2001 | $0.00 | — |
| FY 2000 | $0.00 | — |
| FY 1999 | $0.00 | — |
Source: Cytokinetics, Incorporated SEC filings — income statement (10-K), split-adjusted. Refreshed nightly.
See the full picture for Cytokinetics, Incorporated
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCytokinetics, Incorporated — frequently asked questions
What is Cytokinetics, Incorporated's earnings per share?
Cytokinetics, Incorporated (CYTK) reported earnings per share of $-6.54 for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Cytokinetics, Incorporated's official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.